glp 1 and substance use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) disorders: An emerging pharmacotherapeutic target GLP-1 receptor agonists show promise

Together, these vitamins help restore and maintain adequate vitamin B levels when prescribed by a healthcare professional

Key mechanistic actions include: Enkephalin catabolism inhibition Prolongs the action of leu-enkephalin and met-enkephalin in the CNS BDNF modulation Upregulates brain-derived neurotrophic factor expression in the hippocampus and prefrontal cortex GABAergic system regulation Modulates GABA-A receptor subunit expression, contributing to anxiolytic effects Serotonin system interaction Reduces stress-induced serotonin release in limbic structures Cytokine balance Decreases pro-inflammatory cytokines (IL-1, IL-6) while increasing IL-10 Semax Mechanism of Action Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic analog of ACTH(410) fragment with enhanced stability and CNS penetration

GLP-1 drugs (like Ozempic, Wegovy, and Mounjaro) are legitimate prescription medications for diabetes and weight loss, but they should only be prescribed by a health professional after an in-person consultation

Workforce Our Workforce Collection provides access to the latest insights from Aons Human Capital team on topics ranging from health and benefits, retirement and talent practices